/MDRSF
MDRSF Stock - Medartis Holding AG
Healthcare|Medical - DevicesOTC
$100.00+0.00%
+$0.00 (+0.00%) • Dec 19
72
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.94
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.69
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $110.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for MDRSF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$99.00 – $101.00
TARGET (TP)$115.00
STOP LOSS$92.00
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.27
52W High$102.01
52W Low$66.68
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $224.83M | $212.01M | $182.82M | $159.88M | $127.65M |
| Gross Profit | $178.68M | $167.57M | $135.39M | $121.57M | $93.89M |
| Gross Margin | 79.5% | 79.0% | 74.1% | 76.0% | 73.6% |
| Operating Income | $7.87M | $9.10M | $-1,870,450 | $11.01M | $3.10M |
| Net Income | $3.53M | $619,000 | $-5,782,888 | $6.84M | $-943,565 |
| Net Margin | 1.6% | 0.3% | -3.2% | 4.3% | -0.7% |
| EPS | $0.26 | $0.05 | $-0.49 | $0.58 | $-0.08 |
Company Overview
Medartis Holding AG, a medical device company, develops, manufactures, and sells implant solutions worldwide. Its medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. The company offers osteosynthesis instruments for the areas of the hand, wrist, elbow, shoulder, and foot and ankle, as well as for the areas of the mandible, midface, orthognathic, and cranium under the APTUS and MODUS names. The company serves the surgeons, hospitals, and medical centers, as well as group purchasing organizations. Medartis Holding AG was founded in 1997 and is headquartered in Basel, Switzerland.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
MDRSFBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$0.08
Q4 2024
EPS Surprise History
Q3 21
No data
Q4 21
No data
Q3 22
No data
Q4 22
No data
Q2 23
No data
Q4 23
No data
Q3 24
No data
Q4 24
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Mar 16, 2026 | — | — | — | — |
Q1 2025 | Mar 18, 2025 | — | — | — | — |
Q4 2024 | Dec 31, 2024 | — | $0.08 | — | — |
Q4 2024 | Nov 20, 2024 | — | — | — | — |
Q3 2024 | Aug 20, 2024 | — | $0.21 | — | — |
Q2 2024 | May 15, 2024 | — | — | — | — |
Q4 2023 | Dec 31, 2023 | — | $0.14 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.08 | — | — |
Q1 2023 | Mar 14, 2023 | — | — | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.53 | — | — |
Q3 2022 | Aug 16, 2022 | — | $0.00 | — | — |
Q1 2022 | Mar 7, 2022 | — | — | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.02 | — | — |
Q3 2021 | Aug 17, 2021 | — | $0.65 | — | — |
Q1 2021 | Mar 10, 2021 | — | — | — | — |
Q4 2020 | Dec 31, 2020 | — | $0.47 | — | — |
Q3 2020 | Aug 18, 2020 | — | $-0.52 | — | — |
Q1 2020 | Mar 3, 2020 | — | — | — | — |
Q4 2019 | Dec 31, 2019 | — | $0.13 | — | — |
Q3 2019 | Aug 20, 2019 | — | $0.06 | — | — |
Latest News
Loading news...
Frequently Asked Questions about MDRSF
What is MDRSF's current stock price?
Medartis Holding AG (MDRSF) is currently trading at $100.00 per share. The stock has moved +0.00% today.
What is the analyst price target for MDRSF?
No analyst price targets are currently available for this stock.
What sector is Medartis Holding AG in?
Medartis Holding AG operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the OTC exchange.
What is MDRSF's market cap?
Medartis Holding AG has a market capitalization of $1.24 billion, making it a small-cap company.
Does MDRSF pay dividends?
No, Medartis Holding AG does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBITGF
Biotage AB (publ)
$15.01
Mkt Cap: $1.2B
CMPUY
CompuGroup Medical SE & Co. KGaA
$23.00
Mkt Cap: $1.2B
CMPVF
CompuGroup Medical SE & Co. KGaA
$23.75
Mkt Cap: $1.2B
DGWPF
Drägerwerk AG & Co. KGaA
$72.00
Mkt Cap: $1.4B
DWRKF
Drägerwerk AG & Co. KGaA
$543.70
Mkt Cap: $1.8B
KARBF
Karo Pharma AB (publ)
$5.25
Mkt Cap: $1.5B
KKPCF
Kaken Pharmaceutical Co., Ltd.
$23.65
Mkt Cap: $0.9B
LYPHF
Luye Pharma Group Ltd.
$0.39
Mkt Cap: $1.6B
NPRRF
Nipro Corporation
$8.23
Mkt Cap: $1.3B
SSII
SS Innovations International, Inc.
$5.72
Mkt Cap: $1.1B
Explore stocks similar to MDRSF for comparison